Clinical Trial Detail

NCT ID NCT00983398
Title Melphalan, Carboplatin, and Sodium Thiosulfate for Patients With Central Nervous System (CNS) Embryonal or Germ Cell Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors OHSU Knight Cancer Institute
Indications

germ cell cancer

atypical teratoid rhabdoid tumor

pineoblastoma

ependymoblastoma

medulloepithelioma

medulloblastoma

Therapies

Pegfilgrastim

Filgrastim

Carboplatin + Melphalan

Age Groups: adult child

No variant requirements are available.